semaglutide compound deaths Off-Label Linked to Deaths, Hospitalizations Calling for Compounding Regulation Counterfeit Ozempic Crackdown: Drugmakers Threaten

Cost, Accessibility, and Insurance Coverage Access and affordability remain major challenges

Thus, the growth in GLP-1 RA prescribing among patients with PCOS may reflect a combination of general expansion in GLP-1 RA use and the high prevalence of metabolic indications in this population

Nutrition and healing

A retrospective cohort study on the effects of glucagon-like peptide 1 receptor agonist use on the risk of different obesity-associated malignancies

Moiz, A., Filion, K

British Columbia and Quebec will consider special-authorization requests in narrow cases (very high BMI with severe comorbidities, documented failure of other pharmacotherapy)